Health Canada Reviewed Our Strain — Here's What That Means
Health Canada Reviewed Our Strain — Here's What That Means
Most regulatory news is a badge on a page and nothing else. This one is worth two minutes, because of what got looked at.
This July, Health Canada issued a licence covering OraCMU® — Weissella cibaria CMU. Not a box. Not a flavour. The strain itself, as an ingredient.
Weissella cibaria CMU (OraCMU®)
What actually got reviewed
In Canada, natural health products are reviewed before they can be sold. An ingredient can go through that process on its own — meaning the regulator looks at the ingredient's identity, its safety, how consistently it's made, and the evidence behind what it's permitted to say. That's what happened here, and the result is listed publicly in Health Canada's database.
What this isn't: a number you'll find printed on your Oraticx package here in the US. Ingredient licences don't work that way, and we'd rather say so plainly than let a badge do the implying.
So why is it worth mentioning at all?
Because of the word strain.
This is the thing we bring up constantly, and it's the whole reason this news is interesting: in probiotics, two strains from the same species can behave completely differently. "Weissella cibaria" is a species — a large family. OraCMU® is one specific member of it, originally found in the saliva of healthy children, with its own research behind it.
So a regulator's assessment attaching to that named strain — rather than a general nod at the species — is a more precise thing than it first sounds. It's the same distinction we ask you to apply when you read any probiotic label: not "what species is in here," but "which strain, and what's known about it specifically?"
The licence is public. Look it up yourself:
What it doesn't mean
- It's not FDA approval. It's a Canadian licence. The US regulates these products in a completely different way, and this doesn't carry over. We won't imply otherwise.
- It's not a claim that anything is cured or treated. A licence authorizes specific wording about supporting oral health. It's not permission to say a probiotic treats a disease — because it doesn't.
- A licence isn't proof that something works. It means a regulator reviewed what was submitted. That's meaningful, but it's not the same as evidence, and we'd rather you hear that from us.
The question that actually matters
Not "does it have a number?" but "what research is there on the actual strain, and can I read it?"
W. cibaria CMU has been studied in published, peer-reviewed research — including randomized, placebo-controlled trials in people looking at fresh breath and a balanced oral environment, plus published safety evaluations. Those papers are linked below. Read them, or don't. They're there either way, and that's the point.
Frequently asked questions
A licence number issued by Health Canada for Weissella cibaria CMU (OraCMU®) as a medicinal ingredient. Health Canada reviewed the strain itself — its identity, safety, quality, and the evidence behind what it's authorized to say — rather than reviewing one particular finished product. The licence is listed publicly in Health Canada's database.
No. It's an ingredient licence issued under Canadian regulations, so it isn't printed on US packaging and doesn't apply to products sold in the US. It says something about the strain inside — not about the regulatory status of a product on a US shelf.
No. This is a Canadian licence, and Canada and the US regulate these products in completely different ways. It isn't FDA approval, and it doesn't support any claim for a product sold in the US.
Because it means a regulator assessed the specific named strain rather than the species in general. Strains from the same species can behave very differently, so a review that attaches to one named strain is a more precise thing than a broad species-level assumption.
Not by itself. A licence means a regulator reviewed the evidence submitted. The better question to ask any brand is what published research exists for the actual strain in the product — and whether you can read it yourself.
Sources
- Health Canada. Natural Health Product Licensing Bulletin. canada.ca
- Health Canada. Licensed Natural Health Products Database (LNHPD). health-products.canada.ca
- Han H, Yum H, Cho YD, Kim S. Improvement of halitosis by probiotic bacterium Weissella cibaria CMU: a randomized controlled trial. Front Microbiol. 2023;14:1108762. doi:10.3389/fmicb.2023.1108762
- Dolan LC, Arceneaux BG, Do KH, et al. Toxicological and safety evaluations of Weissella cibaria strain CMU in animal toxicity and genotoxicity. Toxicol Res. 2022;38(3):293–310. doi:10.1007/s43188-021-00119-9
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. NPN 80149686 is a natural health product licence issued by Health Canada under the Natural Health Products Regulations in respect of the medicinal ingredient Weissella cibaria CMU (OraCMU®), subject to its authorized conditions of use in Canada. It does not constitute approval, authorization, or endorsement by the U.S. Food and Drug Administration or any U.S. authority; it does not support any claim for products sold in the United States; and it does not mean that any Oraticx finished product is licensed or reviewed by Health Canada. OraCMU® and OraCMS1® are registered trademarks referring to specific oral-origin Weissella cibaria strains (CMU and CMS1); cited research describes these specific strains and should not be generalized to Weissella cibaria as a species. Content is for educational purposes and is not a substitute for professional dental or medical advice.
